In order to elucidate the mechanism of suppression of plasma aldosterone by chronic ACTH administration, especially the role of the renin-angiotensin system and dopamine, we administered ACTH with or without MK422, a converting enzyme inhibitor, to reduce the endogenous angiotensin II in rats, and measured the plasma renin activity, plasma corticoid concentrations and urinary dopamine excretion.
In order to elucidate the mechanism of suppression of plasma aldosterone by chronic ACTH administration, especially the role of the renin-angiotensin system and dopamine, we administered ACTH with or without MK422, a converting enzyme inhibitor, to reduce the endogenous angiotensin II in rats, and measured the plasma renin activity, plasma corticoid concentrations and urinary dopamine excretion.
The plasma aldosterone concentration (PAC) was decreased after chronic ACTH administration. However, in the ACTH+ MK422 administered group, aldosterone suppression was not observed. It appeared therefore that the aldosterone suppressing mechanism was independent of the weakened renin-angiotensin system following chronic ACTH administration, since PAC was not decreased in the ACTH+ MK422 administered group when angiotensin II might be completely eliminated. The urinary excretion of dopamine was significantly increased in the chronic ACTH +MK422 administered group as well as in the chronic ACTH administered group.
This suggested that the inhibitory effect of dopamine on aldosterone did not contribute significantly to the suppression of plasma aldosterone. The present results suggest therefore that the mechanism of suppression of plasma aldosterone following chronic ACTH administration was not dependent on the renin-angiotensin system and dopamine.
ACTH is not only a major stimulator of glucocorticoid secretion, but is also a very potent stimulator of aldosterone secretion (Williams et al., 1972) . It has been found, however, that after chronic administration of ACTH, plasma aldosterone was decreased despite a high concentration of glucocorticoids (Biglieri et al., 1979 , Rauh et al., 1980 , Nussdorfer et al., 1982 . Various reports have indicated that the mechanisms of suppression of plasma aldosterone by chronic ACTH administration might be related to the renin-angiotensin system (Gaillard et al., 1983) , aldosterone metabolism (Pratt et al., 1976) and inhibition of aldosterone biosynthesis (Muller, 1978 , McDougall et al., 1980 , Nussdorfer et al., 1982 , etc. However, the precise mechanisms have not yet been clarified, and in particular there have been conflicting reports concerning the relation between the renin-angiotensin system and suppression of plasma aldosterone (Gaillard et al,, 1983 , Oelkers, 1985 . Dopamine has been recognized as a physiological inhibitor of aldosterone secretion (McKenna et al,, 1979) . Recently, it was demonstrated that dopamine inhibits (Sowers et al., 1982) . The possibility exists therefore that the inhibitory action of dopamine might lead to suppression of plasma aldosterone.
However, there has been no report on this phenomenon.
In the present study, we examined the plasma aldosterone concentration after chronic ACTH administration with or without a converting enzyme inhibitor in order to assess the possible participation of the renin-angiotensin system in the suppression of plasma aldosterone. At the same time, we measured the urinary excretion of dopamine and prostaglandin E2. cretion of adrenaline and noradrenaline in the chronic ACTH group and chronic ACTH+MK422 group as compared to those in the control group, although a similar tendency was observed in the changes in adrenaline and noradrenaline to that seen in the changes in dopamine (Fig. 3) (Fig. 4) . The urinary excretion of PGE2 was measured in pooled urine collected from 6 rats in each group. The values obtained for the chronic ACTH+MK422 group were surprisingly high ( Table 1) .
The systolic blood pressure in the chronic ACTH group was significantly increased on the 8th day compared to that in the control group and the chronic ACTH+MK422 group (Fig. 5) . The results indicated that the high blood pressure induced by chronic ACTH administration is abolished by the administration of MK422.
The effects of chronic administration of MK422 only on the PRA, corticoids, urinary catecholamines and electrolytes are summarized in Table 2 . The PRA was significantly higher (P<0.01) than that in the control group.
On the other hand, the levels of PAC and other corticoids in the chronic MK422 group were not significantly different from those in the control group. Furthermore, there were no differences in the urinary excretions of catecholamines and electrolytes, and urine volume in these 2 groups (Table 2) .
Discussion
It has been demonstrated by many authors that PAC is increased after acute administration of ACTH, and is decreased after chronic administration of ACTH when the renin-angiotensin system is reduced by elevated mineral corticoids (Biglieri et al., 1979 , Rauh et al., 1980 , Oelkers, 1985 . Conflicting results have been reported for the participation of the reduced reninangiotensin system in the suppression of plasma aldosterone after chronic ACTH administration. Gaillard et al.(1983) found that the suppressed aldosterone response to chronic ACTH administration was more sustained when renin was stimulated by low sodium intake or sodium depletion, suggesting that the suppression of plasma aldosterone was dependent on the reninangiotensin system under normal sodium intake.
On the other hand, Rauh et al. (1980) and Oelkers (1985) observed a reduction of aldosterone after chronic ACTH administration under low sodium intake despite a high renin activity, suggesting that the suppression of plasma aldosterone was independent of the renin-angiotensin system. In order to elucidate the participation of the renin-angiotensin system in the suppression of plasma aldosterone, we administered ACTH chronically to rats concomitantly with MK422, a converting enzyme inhibitor, to reduce the angiotensin II concentration. Regarding the inhibitory effect of MK422 on the renin-angiotensin system, Johnston et al.(1984) investigated the hemodynamic and hormonal effects of a single dose of 10 mg of MK422 in 12 patients with essential hypertension, and demonstrated a similar time course for inhibition of angiotensin converting enzyme, and significant decreses in plasma angiotensin II and aldosterone, with reciprocal increases in blood angiotensin I and plasma renin. Recently, several reports have suggested that dopamine plays a role in the regulation of aldosterone secretion (Carey et al., 1979 , McKenna et al., 1979 . The aldosterone regulatory role of dopamine has been found to be as a tonic inhibitor and to be independent of the renin-angiotensin system (Sower et al., 1980) . It has been reported that the site of dopamine inhibition of aldosterone in the adrenal gland was at a late step, especially 18-hydroxylase (McKenna et al., 1979 , Sowers et al., 1982 . We measured urinary dopamine excretion in an attempt to evaluate the relatianship of dopamine to the suppression of plasma aldosterone, since it has been established that the plasma levels of aldosterone and1 8-deoxy-corticosterone, at the late step of the adrenal gland, were decreased after chronic ACTH administration (Biglieri et al., 1979 , Oelkers, 1985 .
At the same time, Baines and Chan, (1980) reported that 30% of the urinary dopamine is derived from circulating free L-dopa based on a micropuncture study of nephrotubules.
It is considered therefore that the urinary dopamine can be used as an index in evaluating the relationship between dopamine and aldosterone. On the other hand, dopamine was found to be increased after sodium loading and to act to reduce blood pressure by a vasodilatory action, enhancing effects on the glomerular filtration rate and natriuresis by inhibiting sodium reabsorption (Lee, 1982) .
In the present series of experiments, the significant increases in urinary dopamine excretion in the chronic ACTH group and the chronic ACTH+MK422 group appeared to be attributable to sodium retention and volume expansion due to the significantly increased mineral corticoids, such as DOC. Furthermore, an increase in urine volume without any increase in sodium excretion was recognized in the 2 groups. It is possible that the increased urine volume was due to the action of dopamine which was increased in response to the increase in mineralcorticoids.
Regarding the participation of increased dopamine in suppressing plasma aldosterone in the present series of experiments, the increase in dopamine appeared to be independent of the suppression of plasma aldosterone by chronic ACTH administration, since in the chronic ACTH+MK422 group PAC was not decreased in spite of an increase in dopamine to a level as high as that in the chronic ACTH group.
It has been reported that during prolonged ACTH treatment, zona glomerulosa cells may be converted to functional zona fasciculata type cells (Muller, 1978 , McDougall et al., 1980 , Nussdorfer et al., 1982 
